Integrating Pharmacoproteomics into Early-Phase Clinical Development: State-of-the-Art, Challenges, and Recommendations

Pharmacoproteomics is the study of disease-modifying and toxicity parameters associated with therapeutic drug administration, using analysis of quantitative and temporal changes to specific, predetermined, and select proteins, or to the proteome as a whole. Pharmacoproteomics is a rapidly evolving f...

Descripción completa

Detalles Bibliográficos
Autores principales: Nandal, Savita, Burt, Tal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5343982/
https://www.ncbi.nlm.nih.gov/pubmed/28218733
http://dx.doi.org/10.3390/ijms18020448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5343982/
https://www.ncbi.nlm.nih.gov/pubmed/28218733
http://dx.doi.org/10.3390/ijms18020448

Ejemplares similares